Helen Torley: CEO of Halozyme Therapeutics

Portrait of Helen Torley

Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.

Shionogi

An Opportunity Pipeline

Overseas Shipholding Group

Moving Energy with Integrity

Regeneron Annual Report Cover Detail
Regeneron

Annual Report